Growth Metrics

Boston Scientific (BSX) Total Non-Current Liabilities (2009 - 2026)

Boston Scientific recorded quarterly Total Non-Current Liabilities of $15.8 billion in Q1 2026, down 6.06% quarter-over-quarter from $16.8 billion in Q4 2025, and little changed year-over-year from $15.7 billion in Q1 2025.

Boston Scientific's Total Non-Current Liabilities history runs 18 years deep, the most recent figure standing at $15.8 billion for Q1 2026.

  • In Q1 2026, Total Non-Current Liabilities changed 0.19% year-over-year to $15.8 billion; the TTM figure through Mar 2026 stood at $15.8 billion (changed 0.19% YoY), while the FY2025 annual figure was $16.8 billion, up 6.61% from the prior year.
  • Total Non-Current Liabilities came in at $15.8 billion for Q1 2026 at Boston Scientific, down from $16.8 billion in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $35.3 billion in Q2 2024 to a low of $10.1 billion in Q2 2022.
  • A 5-year average of $21.1 billion and a median of $16.7 billion in 2025 frame the typical range for Total Non-Current Liabilities.
  • Across the five-year window, Total Non-Current Liabilities sank 65.13% in 2022 and jumped 211.11% in 2023, its largest moves.
  • Boston Scientific's Total Non-Current Liabilities stood at $30.2 billion in 2022, then plunged by 54.79% to $13.6 billion in 2023, then gained by 15.51% to $15.8 billion in 2024, then advanced by 6.61% to $16.8 billion in 2025, then retreated by 6.06% to $15.8 billion in 2026.
  • According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $15.8 billion, $16.8 billion, and $16.7 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 20.94 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 40.52 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 15.78 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 2.44 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 9.85 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 3.53 Bn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 24.21 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 3.47 Bn
10 Zimmer Biomet Holdings 16.17 Bn 15.75 Bn 1.51 Bn 9.41 Bn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 15.78 Bn
Dec 31, 2025 16.80 Bn
Sep 30, 2025 16.69 Bn
Jun 30, 2025 17.95 Bn
Mar 31, 2025 15.75 Bn
Dec 31, 2024 15.76 Bn
Sep 30, 2024 15.53 Bn
Jun 30, 2024 35.32 Bn
Mar 31, 2024 33.44 Bn
Dec 31, 2023 13.64 Bn
Sep 30, 2023 13.30 Bn
Jun 30, 2023 31.42 Bn
Mar 31, 2023 33.15 Bn
Dec 31, 2022 30.17 Bn
Sep 30, 2022 12.39 Bn
Jun 30, 2022 10.10 Bn
Mar 31, 2022 31.63 Bn
Dec 31, 2021 29.99 Bn
Sep 30, 2021 13.12 Bn
Jun 30, 2021 28.96 Bn
Mar 31, 2021 30.78 Bn
Dec 31, 2020 28.47 Bn
Sep 30, 2020 15.07 Bn
Jun 30, 2020 30.29 Bn
Mar 31, 2020 31.61 Bn
Dec 31, 2019 27.66 Bn
Sep 30, 2019 30.60 Bn
Jun 30, 2019 22.27 Bn
Mar 31, 2019 4.37 Bn
Dec 31, 2018 26.07 Bn
Sep 30, 2018 18.59 Bn
Jun 30, 2018 19.39 Bn
Mar 31, 2018 18.67 Bn
Dec 31, 2017 -489.00 Mn
Sep 30, 2017 9.31 Bn
Jun 30, 2017 9.18 Bn
Mar 31, 2017 9.02 Bn
Dec 31, 2016 17.48 Bn
Sep 30, 2016 8.21 Bn
Jun 30, 2016 8.38 Bn
Mar 31, 2016 8.33 Bn
Dec 31, 2015 15.14 Bn
Sep 30, 2015 8.80 Bn
Jun 30, 2015 7.91 Bn
Mar 31, 2015 7.27 Bn
Dec 31, 2014 23.05 Bn
Sep 30, 2014 7.29 Bn
Jun 30, 2014 7.33 Bn
Mar 31, 2014 7.40 Bn
Dec 31, 2013 15.59 Bn
Sep 30, 2013 7.77 Bn
Jun 30, 2013 7.84 Bn
Mar 31, 2013 7.60 Bn
Dec 31, 2012 -1.82 Bn
Sep 30, 2012 7.77 Bn
Jun 30, 2012 7.85 Bn
Mar 31, 2012 7.80 Bn
Dec 31, 2011 23.66 Bn
Sep 30, 2011 8.00 Bn
Jun 30, 2011 8.01 Bn
Mar 31, 2011 8.70 Bn
Dec 31, 2010 20.47 Bn
Sep 30, 2010 10.01 Bn
Jun 30, 2010 10.89 Bn
Mar 31, 2010 10.55 Bn
Dec 31, 2009 7.03 Bn
Sep 30, 2009 11.08 Bn
Jun 30, 2009 10.84 Bn